Depping M S, Köhler-Ipek L, Ullrich P, Hauer K, Wolf R C
Klinik für Allgemeine Psychiatrie, Zentrum für Psychosoziale Medizin, Universitätsklinikum Heidelberg, Voßstr. 4, 69115, Heidelberg, Deutschland.
Geriatrisches Zentrum an der Medizinischen Fakultät der Universität Heidelberg, Agaplesion Bethanien Krankenhaus Heidelberg, Rohrbacher Str. 149, 69126, Heidelberg, Deutschland.
Nervenarzt. 2023 Mar;94(3):234-239. doi: 10.1007/s00115-023-01444-0. Epub 2023 Feb 17.
Depression is the most common mental disorder in older adults and is influenced by age-related processes. Frailty is a well-established clinical expression of ageing that implies a state of increased vulnerability to stressor events as well as increased risks of disability, hospitalization and death. Neurobiological findings will disentangle the comorbidity of frailty and depression and may inform future management of depression in old age.
This narrative review provides an overview of the comorbidity of late-life depression and frailty, with a focus on neuroscientific findings that are organized within the research domain criteria (RDoC) framework.
More than one third of old people with depression are affected by frailty, which results in more chronic depression and in poorer efficacy and tolerability of antidepressant medication. Depression and frailty share motivational and psychomotor characteristics, particularly apathy, decreased physical activity and fatigue. In patients with frailty, altered activity of the supplementary motor cortex is associated with motor performance deficits. Patients with late-life depression and apathy are characterized by abnormal structure and altered functional connectivity of the reward network and the salience network, along with altered functional connectivity of these networks with premotor brain areas.
Identifying frailty in older adults with depression is relevant for prognostic assessment and treatment. A better understanding of the neuronal mechanisms of comorbidity will provide potential targets for future personalized therapeutic interventions.
抑郁症是老年人中最常见的精神障碍,受与年龄相关的过程影响。衰弱是一种公认的衰老临床表征,意味着对压力源事件的易感性增加,以及残疾、住院和死亡风险增加。神经生物学研究结果将厘清衰弱与抑郁症的共病情况,并可能为未来老年抑郁症的管理提供依据。
本叙述性综述概述了老年抑郁症与衰弱的共病情况,重点关注在研究领域标准(RDoC)框架内组织的神经科学研究结果。
超过三分之一的抑郁症老年人受到衰弱影响,这导致更多的慢性抑郁症,以及抗抑郁药物的疗效和耐受性较差。抑郁症和衰弱具有动机和精神运动特征,特别是冷漠、身体活动减少和疲劳。在衰弱患者中,辅助运动皮层的活动改变与运动表现缺陷有关。老年抑郁症和冷漠患者的特征是奖赏网络和突显网络的结构异常和功能连接改变,以及这些网络与运动前脑区的功能连接改变。
识别抑郁症老年人中的衰弱与预后评估和治疗相关。更好地理解共病的神经元机制将为未来的个性化治疗干预提供潜在靶点。